Exploring the Protective Mechanism of Baicalin in Treatment of Atherosclerosis Using Endothelial Cells Deregulation Model and Network Pharmacology

Overview

Journal BMC Complement Med Ther

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2022 Oct 3

PMID 36192741

Authors

Mingshuang Li

Conglin Ren

Affiliations

Soon will be listed here.

Abstract

Background: Baicalin is a generally available flavonoid with potent biological activity. The present study aimed to assess the underlying mechanism of baicalin in treatment of atherosclerosis (AS) with the help of network pharmacology, molecular docking and experimental validation.

Methods: The target genes of baicalin and AS were identified from public databases, and the overlapping results were considered to be baicalin-AS targets. Core target genes of baicalin were obtained through the PPI network and validated by a clinical microarray dataset (GSE132651). Human aortic endothelial cells (HAECs) were treated with Lipopolysaccharide (LPS) to construct an endothelial injury model. The expression of NOX4 was examined by real-time qPCR and western blot. Flow cytometry was used to detect intracellular levels of reactive oxygen species (ROS). Furthermore, HAECs were transfected with NOX4-specific siRNA and then co-stimulated with baicalin and LPS to investigate whether NOX4 was involved in the anti-oxidative stress effects of baicalin.

Results: In this study, baicalin had 45 biological targets against AS. Functional enrichment analysis demonstrated that most targets were involved in oxidative stress. Using the CytoHubba plug-in, we obtained the top 10 genes in the PPI network ranked by the EPC algorithm. Molecular docking and microarray dataset validation indicated that NOX4 may be an essential target of baicalin, and its expression was significantly suppressed in AS samples compared to controls. In endothelial injury model, intervention of HAECs with baicalin increased the expression levels of NOX4 and NOS3 (eNOS), and decreased LPS-induced ROS generation. After inhibition of NOX4, the anti-ROS-generating effect of baicalin was abolished.

Conclusion: Collectively, we combined network pharmacology and endothelial injury models to investigate the anti-AS mechanism of baicalin. The results demonstrate that baicalin may exert anti-oxidative stress effects by targeting NOX4, providing new mechanisms and insights to baicalin for the treatment of AS.

Citing Articles

Pharmacological mechanisms by which baicalin ameliorates cardiovascular disease.

Si L, Lai Y Front Pharmacol. 2024; 15:1415971.

PMID: 39185317 PMC: 11341428. DOI: 10.3389/fphar.2024.1415971.

Phytochemical analysis, and study of antiproliferative activity of ethyl acetate fraction of (Hochst. ex Oliv. & Hiern) C. Jeffrey against human cervical cancer cell line.

Lagu I, Nyamai D, Njeru S Front Pharmacol. 2024; 15:1399885.

PMID: 39005932 PMC: 11239972. DOI: 10.3389/fphar.2024.1399885.

Molecular targets and therapeutic potential of baicalein: a review.

Munjal K, Goel Y, Gauttam V, Chopra H, Singla M, Smriti Drug Target Insights. 2024; 18:30-46.

PMID: 38873988 PMC: 11168303. DOI: 10.33393/dti.2024.2707.

References

Hou J, Wang J, Zhang P, Li D, Zhang C, Zhao H . Baicalin attenuates proinflammatory cytokine production in oxygen-glucose deprived challenged rat microglial cells by inhibiting TLR4 signaling pathway. Int Immunopharmacol. 2012; 14(4):749-57. DOI: 10.1016/j.intimp.2012.10.013. View

Frostegard J . Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013; 11:117. PMC: 3658954. DOI: 10.1186/1741-7015-11-117. View

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

Craige S, Kant S, Reif M, Chen K, Pei Y, Angoff R . Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions. Free Radic Biol Med. 2015; 89:1-7. PMC: 4783146. DOI: 10.1016/j.freeradbiomed.2015.07.004. View

Schurmann C, Rezende F, Kruse C, Yasar Y, Lowe O, Fork C . The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur Heart J. 2015; 36(48):3447-56. PMC: 4751217. DOI: 10.1093/eurheartj/ehv460. View

Salazar G . NADPH Oxidases and Mitochondria in Vascular Senescence. Int J Mol Sci. 2018; 19(5). PMC: 5983750. DOI: 10.3390/ijms19051327. View

Baradaran Rahimi V, Askari V, Hosseinzadeh H . Promising influences of Scutellaria baicalensis and its two active constituents, baicalin, and baicalein, against metabolic syndrome: A review. Phytother Res. 2021; 35(7):3558-3574. DOI: 10.1002/ptr.7046. View

Serafini M, Peluso I, Raguzzini A . Flavonoids as anti-inflammatory agents. Proc Nutr Soc. 2010; 69(3):273-8. DOI: 10.1017/S002966511000162X. View

Takac I, Schroder K, Zhang L, Lardy B, Anilkumar N, Lambeth J . The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem. 2011; 286(15):13304-13. PMC: 3075677. DOI: 10.1074/jbc.M110.192138. View

10.

Keiser M, Roth B, Armbruster B, Ernsberger P, Irwin J, Shoichet B . Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007; 25(2):197-206. DOI: 10.1038/nbt1284. View

11.

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S . The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016; 54:1.30.1-1.30.33. DOI: 10.1002/cpbi.5. View

12.

Wang Z, Jiang Z, Xiao P, Jiang Y, Liu W, Liu E . The mechanisms of baicalin ameliorate obesity and hyperlipidemia through a network pharmacology approach. Eur J Pharmacol. 2020; 878:173103. DOI: 10.1016/j.ejphar.2020.173103. View

13.

Gray S, Di Marco E, Kennedy K, Chew P, Okabe J, El-Osta A . Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling. Arterioscler Thromb Vasc Biol. 2015; 36(2):295-307. DOI: 10.1161/ATVBAHA.115.307012. View

14.

Zhang L, Yu J, Zhou Y, Shen M, Sun L . Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19). Am J Chin Med. 2020; 48(4):763-777. DOI: 10.1142/S0192415X2050038X. View

15.

Dong L, Wen J, Miao S, Jia Z, Hu H, Sun R . Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia. Cell Res. 2010; 20(11):1252-62. DOI: 10.1038/cr.2010.111. View

16.

Zhang M, Yuan Y, Zhou W, Qin Y, Xu K, Men J . Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease. Comput Biol Chem. 2020; 86:107248. DOI: 10.1016/j.compbiolchem.2020.107248. View

17.

Boezio B, Audouze K, Ducrot P, Taboureau O . Network-based Approaches in Pharmacology. Mol Inform. 2017; 36(10). DOI: 10.1002/minf.201700048. View

18.

Guzik T, Chen W, Gongora M, Guzik B, Lob H, Mangalat D . Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol. 2008; 52(22):1803-9. PMC: 2593790. DOI: 10.1016/j.jacc.2008.07.063. View

19.

Li L, Bao H, Wu J, Duan X, Liu B, Sun J . Baicalin is anti-inflammatory in cigarette smoke-induced inflammatory models in vivo and in vitro: A possible role for HDAC2 activity. Int Immunopharmacol. 2012; 13(1):15-22. DOI: 10.1016/j.intimp.2012.03.001. View

20.

Schroder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J . Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res. 2012; 110(9):1217-25. DOI: 10.1161/CIRCRESAHA.112.267054. View